• About Us
  • Research
  • Strategy
  • Contact Us
  • ⌕
  • Home
  • About Us
    • Cross-border Mergers
    • Antitrust & Competition Law
    • Hostile Takeovers
    • Shareholder Analysis
    • SPACs
    • Financial Valuation
    • Takeover Codes
    • Risk Arbitrage Trading Strategies
    • Merger Database
    • Join our Team
  • Research
    • Reports
      • WS Atkins/SNC-Lavalin Group
        • Potential M&A Activism and Bumpitrage
        Monsanto/Bayer
        • International Antitrust Scrutiny
        Delta Lloyd/NN Group
        • Pre-Event Risks, the Stichting and Shareholder Reactions
        SABMiller/AB InBev
        • Scheme Vote Considerations
        • Proxy Adviser Risks
        Inmarsat/Apax, Warburg Pincus, CPPIB, OTPP
        • Private Equity vs Public Market – Regulatory and Counterbid Thoughts
        • Ligado Uncertainty and Optionality – Pre- or Post-Vote
        • UK National Security, Ligado and Antitrust Updates
        Fitbit/Alphabet
        • Fitbit’s Data and its Conglomerate and Vertical Effects
        Sky/Twenty-First Century Fox
        • "Non-Fanciful Concerns" and New Deal Risks
        • UK Political Impacts on the Sky-Fox Deal
        • Heading into 29 June Announcement
        • Opportunities and Risks For M&A Activism
        • The CMA’s Findings and the ‘Event-Based’ Sunset Clause
        • The Disney Effect and UK Chain Principle Considerations
        • Comcast’s Intentions and Whether Fox or Disney Comes Back
        • Effects of the DoJ’s Appeal Against AT&T and Comcast’s Intentions
        • Public Interest and Fit and Proper Analysis
        Linde/Praxair
        • Antitrust Implications and Break Prices
        • US and China Antitrust Analysis; Breaching the Divestiture Cap
        Amer Sports Group/Anta Sports-led Consortium
        • CFIUS’ National Security Considerations and Financing Stability
        Luxottica Group/Essilor International
        • MOFCOM Secured, Squeeze-Out and Sell-Out Optionality
        NEX Group/CME Group
        • Exploring the Overlooked Antitrust Risks
        TLG/Aroundtown
        • Back-Ends in All-Stock, No Minimum Acceptance, Real Estate Deals
        Technip/FMC Technologies
        • Mergers-of-Equals and Negative Arb Spreads
        Syngenta/ChemChina
        • Sources of Funds
        • CFIUS Analysis, Monsanto
        • Loan Refinancing Considerations
        WellCare Health Plans/Centene Corporation
        • Antitrust Assessment and Other Deal Considerations
        Tribune Media/Nexstar Media Group
        • A Different Approach to Sinclair
        European LBOs/Axel Springer, Cobham, Inmarsat, Merlin and Osram
        • Trends, Structures, Candidates
        GKN/Melrose Industries
        • Bumping, Waiving and Extending in UK Hostile Deals
        Zodiac/Safran
        • Assessing the Consequences of Zodiac’s Profit Warnings
        Huntsman/Clariant
        • Post-Mortem: Companies Terminate Merger, Break Prices
        Scout24/Hellman & Friedman and Blackstone
        • The 50%+1, Bestellerprinzip Risk and Optionality
        Kuka/Midea
        • Update on CFIUS and ITAR Reviews
        • Implications of the BMWi Certificate Withdrawal of Aixtron / Grand Chip
        • German Protectionism and CFIUS Scrutiny
        Shire/Takeda
        • Weighing Upside Versus the Acquirer Vote and Pipeline Risks
        • Heading into the Takeda AGM on 28 June 2018
        Tiffany/LVMH
        • Specific Performance, French Government Intervention, Outcomes
        • Reprice and ‘Out’ Viability, Pandemic Impact
        LINE/Softbank & NAVER
        • Antitrust and Data, Squeeze-Outs and Appraisal Rights
        NXP Semiconductors/Qualcomm
        • Conflicting Break Price Analyses
        • Not Over Yet. Revisiting Break Prices and Trade Tariffs
        Spark Therapeutics/Roche Holding
        • Implications of Pull-and-Refiles and a Second Request
        Uniper/Fortum
        • Bumping Offers Versus Building Stakes in German M&A
        Red Hat/IBM
        • Vertical Limit: The Cloud, Linux and European Antitrust Scrutiny
        Meda/Mylan
        • VEB, the Dutch Enterprise Chamber, and Deal Collars
        Jardine Lloyd Thompson/Marsh & McLennan
        • Regulatory Risks and Entry Points
        Actelion/Johnson & Johnson
        • Uptravi Assessment and the R&D NewCo Spin-off
        Allergan/AbbVie
        • Antitrust Complications and Considerations
        Twenty-First Century Fox/Disney
        • Impact of AT&T, over Disney, and across Sky
        • Counterbids and Leverage, Governance and Antitrust Issues
        • Brazil Antitrust, Collar and Election Strategies, New Fox Value
        Abertis/Atlantia
        • M&A Re-Rating and Counterbid/Bump Scenarios
        • Reactions and Thoughts on the Hochtief Counterbid
        Worldpay/Vantiv
        • M&A Acquirer Activism and Standalone Values
        • Target and Acquirer Susceptibility to a Counterbid
        London Stock Exchange/Deutsche Boerse
        • Other Suitors, the UK Referendum and Antitrust Risks
        Celgene/Bristol-Myers Squibb
        • Buyers for BMS, Merger Agreement Strength, Antitrust and Activism
        Amec Foster Wheeler/John Wood Group
        • Antitrust, Interloper and Break Price Risks
        FLIR Systems/Teledyne Technologies
        • New Deal Insights
        ARM Holdings/SoftBank Group
        • Committed Buyer, Swift Timeline to Completion
        Cayman-Incorporated/US-Listed Chinese Takeovers
        • Back-End Risks and Opportunities for Dissenters
        Com Hem/Tele2
        • Manageable Antitrust and Break Scenarios, Plus Optionality
        Gemalto/Thales
        • EC Phase II Antitrust, CFIUS and Downside Risks
        Time Warner/AT&T
        • From the Court House – Closing Arguments
        • Expected Verdict, Unwavering Confidence and Crowdedness
        • Precedent Parallels: EC-Blocked Vertical / Conglomerate Mergers
        Fiat Chrysler Automobiles/Peugeot
        • Pre-Deal Hurdles, Rationale and Deal Structure
        GW Pharmaceuticals/Jazz Pharmaceuticals
        • New Deal Insights
        Natixis/Groupe BPCE
        • New Deal Insights
        PRA Health Sciences/ICON
        • New Deal Insights
        Signature Aviation/Global Infrastructure Partners
        • New Deal Insights
        RSA Insurance Group/Insurer Consortium
        APA Group/CK Infrastructure Holdings
        • Australian Politics, National Security and Chinese Influence
        • Call with Our Australian Legal Advisers
        COVID-19/Impact on Pending Leveraged Buyouts
        • Broken Deals, Sponsor Optionality and Target Remedies
        COVID-19 /Impact on Pending European Public M&A
        • Conditionality, Covenants, Precedents and ‘Outs’
        Dialog Semiconductor/Renesas Electronics
        • New Deal Insights
        Aggreko/TDR and I Squared Consortium
        • New Deal Insights
        Gamesys Group/Bally's
        • New Deal Insights
        Athene Holding/Apollo Global Management
        • New Deal Insights
        GrandVision/EssilorLuxottica
        • Cut and Termination Scenarios
        Hella/Faurecia
        • New Deal Insights
        Kansas City Southern/Canadian Pacific Railway
        • New Deal Insights
        Siltronic/GlobalWafers
        • New Deal Insights
        What to Expect from China's SAMR/Dialog, Inphi, Maxim, Siltronic, and Xilinx
        • In-Depth Report
        COVID-19/Impact on Pending US Public M&A
        • Carve-Outs, Financing, Solvency, Fees, Specific Performance
        China's SAMR/What to Expect from China’s SAMR in Semiconductor Merger Control
        Change Healthcare/UnitedHealth Group
        • New Deal Insights
        RealPage/Thoma Bravo
        • New Deal Insights
        Catalent/Novo Holdings
        • Deal Insight
        The Stars Group/Flutter Entertainment
        • Global Antitrust and Notable Deal-Related Risks
        Alexion/AstraZeneca
        • New Deal Insights
        Slack Technologies/Salesforce.com
        • New Deal Insights
        Willis Towers Watson/Aon
        • US Antitrust Catalysts: Settlement, Trial or Termination
        Brookfield Property Partners/Brookfield Asset Management
        • New Deal Insights
        Boral/Seven Group Holdings
        • New Deal Insights
        Beijing Jingneng Clean Energy/Beijing Energy Holding
        China Biologic Products/Centurium-led Consortium
        Eaton Vance/Morgan Stanley
        PPD/Thermo Fisher
        • New Deal Insights
        Randgold Resources/Barrick Gold
        • Regulatory and Political Considerations; Nil-Premium Opportunities
        Swedish Orphan Biovitrum/Advent Int'l, GIC
        • New Deal Insights
        Acceleron Pharma/Merck & Co
        • New Deal Insights
        Inovalon/Nordic Capital-led Consortium
        • New Deal Insights
        Hill-Rom Holdings/Baxter
        • New Deal Insights
        Deutsche Wohnen/Vonovia
        • New Deal Insights
        Five9/Zoom Video Communications
        • New Deal Insights
        Iliad Group/Xavier Niel
        • New Deal Insight
        Proofpoint/Thoma Bravo
        • New Deal Insights
        Spark Infrastructure Group/KKR, OTPP, PSPIB
        • New Deal Insights
        UDG Healthcare/Clayton, Dubilier & Rice
        • New Deal Insights
        Zooplus/Hellman & Friedman
        • New Deal Insights
        Entra/Balder
        • New Deal Insights
        Lundin Energy/Aker BP
        • Deal Insights
        Afterpay/Square
        • New Deal Insight
        Alstria Office REIT/Brookfield Asset Management
        • Deal Insights
        Daily Mail & General Trust/Rothermere Continuation
        • Deal Insights
        Kansas City Southern/Canadian National Railway
        • New Deal Insights
        Kirkland Lake Gold/Agnico Eagle Mines
        • New Deal Insights
        Immofinanz/CPI
        • Deal Insights
        Oil Search/Santos
        • New Deal Insights
        Sydney Airport/Sydney Aviation Alliance
        • Deal Insights
        Avast/NortonLifeLock
        • New Deal Insights
        IHS Markit/S&P Global
        • New Deal Insights
        Nuance/Microsoft
        • New Deal Insights
        McAfee/Advent-led Investor Group
        • Deal Insights
        CyrusOne/KKR, Global Infrastructure Partners
        • Deal Insights
        Arena Pharmaceuticals/Pfizer
        • Deal Insights
        Ultra Electronics and Meggitt/Revisiting UK National Security Trends
        • In-Depth Report
        SailPoint/Thoma Bravo
        • Deal Insights
        51job/DCP Capital, Ocean Link, Rick Yan
        • New Deal Insights
        Anaplan/Thoma Bravo
        • Deal Insights
        Cerner/Oracle
        • Deal Insights
        Healthcare Trust of America/Healthcare Realty Trust
        • Deal Insights
        Crown Resorts/Blackstone Group
        • New Deal Insights
        • Deal Insights
        Lagardère/Vivendi
        • New Deal Insights
        Vifor Pharma/CSL
        • Deal Insights
        Zynga/Take-Two Interactive
        • Deal Insights
        Change Healthcare/UnitedHealth Group
        • In-Depth Report
        Meggitt/Parker-Hannafin
        • New Deal Insight
        Meritor/Cummins
        • Deal Insights
        Link Administration Holdings/Dye & Durham
        • Deal Insights
        Ultra Electronics/Cobham
        • New Deal Insights
        Alleghany/Berkshire Hathaway
        • Deal Insights
        Hitachi Metals/Bain Capital-led Consortium
        • New Deal Insights
        MGM Growth Properties/VICI Properties
        • New Deal Insights
        Atlantia/Edizione & Blackstone
        • Deal Insights
        Euronav/Frontline
        • Deal Insights
        HomeServe/Brookfield Asset Management
        • Deal Insights
        Tenneco/Apollo Global Management
        • Deal Insights
        First Horizon/TD Bank
        • Deal Insights
        Tegna/Standard General
        • Deal Insights
        Black Knight/ICE
        • Deal Insights
        Activision Blizzard/Microsoft
        • In-Depth Report
        • Deal Insights
        VMware/Broadcom
        • Deal Insights
        MorphoSys/Novartis
        • Deal Insight
        Biohaven Pharmaceuticals/Pfizer
        • Deal Insights
        Duke Realty/Prologis
        • Deal Insights
        Ramsay Health Care/KKR
        • Deal Insights
        Global Blood Therapeutics/Pfizer
        • Deal Insights
        Avalara/Vista
        • Deal Insights
        Alteryx/Clearlake Capital Group
        • Deal Insight
        Aveva/Schneider
        • Deal Insights
        Hitachi Transport System/KKR
        • Deal Insights
        Swedish Match/Philip Morris International
        • Deal Insights
        Twitter/Elon Musk
        • Deal Insights
        Twitter/Elon Musk
        • In-Depth Report
        AusNet Services/Brookfield Asset Management
        • Deal Insights
        1Life Healthcare/Amazon
        • Deal Insights
        Altra Industrial/Regal Rexnord
        • Deal Insight
        Abiomed/Johnson & Johnson
        • Deal Insight
        Coupa Software/Thoma Bravo
        • Deal Insight
        Duck Creek Technologies/Vista Equity Partners
        • Deal Insight
        Evoqua Water Technologies/Xylem
        • Deal Insight
        IAA/Ritchie Bros
        • Deal Insight
        KnowBe4/Vista Equity Partners
        • Deal Insight
        Maxar Technologies/Advent International
        • Deal Insights
        OZ Minerals/BHP Group
        • Deal Insight
        Shaw Communications/Rogers Communications
        • New Deal Insights
        Signify Health/CVS Health
        • Deal Insights
        STORE Capital/GIC, Oak Street
        • Deal Insights
        Vantage Towers/Vodafone, GIP, KKR
        • Deal Insight
        Telenet Group Holdings/Liberty Global
        • Deal Insights
        Amedisys/Option Care Health
        • Deal Insights
        Credit Suisse Group/UBS Group
        • Deal Insights
        EngageSmart/Vista Equity Partners
        • Deal Insight
        iRobot/Amazon
        • Deal Insights
        Itochu Techno-Solutions/Itochu
        • Deal Insight
        Life Storage/Extra Space Storage
        • Deal Insights
        NuVasive/Globus Medical
        • Deal Insights
        Qualtrics/Silver Lake
        • Deal Insights
        PDC Energy/Chevron
        • Deal Insights
        Prometheus/Merck
        • Deal Insights
        SimCorp/Deutsche Boerse
        • Deal Insights
        Reata Pharmaceuticals/Biogen
        • Deal Insightss
        Toshiba/JIP-led Consortium
        • Deal Insights
        Triton/Brookfield Infrastructure
        • Deal Insights
        Univar Solutions/Apollo Management, ADIA
        • Deal Insights
        Hess/Chevron
        • Deal Insight
        Horizon Therapeutics/Amgen
        • Deal Insight
        Majorel/Teleperformance
        • Deal Insights
        Newcrest/Newmont
        • Deal Insights
        National Instruments /Emerson Electric
        • Deal Insights
        NWS Holdings/CTFE
        • Deal Insights
        Crestwood/Energy Transfer
        • Deal Insights
        Hostess Brands/JM Smucker
        • Deal Insight
        Seagen/Pfizer
        • Deal Insights
        Karuna Therapeutics/Bristol-Myers Squibb
        • Deal Insight
        Dechra/EQT, ADIA
        • Deal Insights
        • Exploring CMA Jurisdiction
        Euronav/CMB
        • Deal Insight
        Origin Energy/Brookfield
        • Deal Insight
        Mirati Therapeutics/Bristol-Myers Squibb
        • Deal Insight
        Telefonica Deutschland Holding/Telefonica
        • Deal Insight
        Vitesco/Schaeffler
        • Deal Insight
        ImmunoGen/AbbVie
        • Deal Insight
        Spirit Airlines/Frontier Group Holdings
        • Deal Insights
        Cerevel Therapeutics/AbbVie
        • Deal Insight
        JSR/JIC
        • Deal Insights
        Pioneer/Exxon
        • Deal Insight
        WestRock/Smurfitt Kappa
        • Deal Insight
        Abcam/Danaher
        • Deal Insight
        Juniper Networks/Hewlett Packard
        • Deal Insight
        • Antitrust Risks and Break Price Analysis
        Southwestern Energy/Chesapeake Energy
        • Deal Insight
        Albertsons/Kroger
        • Deal Insights
        United States Steel/Nippon Steel
        • Deal Insight
        Ansys/Synopsys
        • Deal Insight
        Chr. Hansen/Novozymes
        • Deal Insight
        Rover Group/Blackstone
        • Deal Insight
        ChampionX/SLB
        • Deal Insight
        Vinda/APRIL Group
        • Deal Insight
        Lawson/KDDI
        • Deal Insight
        Banco de Sabadell/BBVA
        • Deal Insight
        HashiCorp/IBM
        • Deal Insight
        Kellanova/Mars
        • Deal Insight
        Altium/Renesas
        • Deal Insight
        Alumina/Alcoa
        • Deal Insight
        CSR/Compagnie de Saint Gobain
        • Deal Insight
        Shockwave/Johnson & Johnson
        • Deal Insight
        Redrow/Barratt Developments
        • Deal Insigth
        Frontier Communications/Verizon Communications
        • Deal Insight
        Covestro/ADNOC
        • Deal Inisght
        • Navigating the EU Foreign Subsidies Regulation (FSR) and German National Security (BMWE)
        Banco BPM/UniCredit
        • Deal Insight
        Capri/Tapestry
        • Deal Insights
        • Thoughts on the Trial
        Darktrace/Thoma Bravo
        • Deal Insight
        Kindred Group/La Francaise des Jeux
        • Deal Insight
        Nuvei/Advent International
        • Deal Insight
        Stericycle/Waste Management
        • Deal Insight
        Virgin Money/Nationwide Building Society
        • Deal Insight
        ESR Group/Starwood-led Consortium
        • Deal Insight
        Direct Line/Aviva
        • Deal Insight
        Interpublic Group of Companies/Omnicom Group
        • Deal Insight
        Avangrid/Iberdrola
        • Deal Insight
        Britvic/Carlsberg
        • Deal Insight
        Encavis/KKR-led Consortium
        • Deal Insight
        Marathon Oil/ConocoPhillips
        • Deal Insight
        Smartsheet/Blackstone-Vista
        • Deal Insight
        Mediobanca/Banca Monte dei Paschi di Siena
        • Deal Insight
        Just Eat Takeaway/Prosus
        • Deal Insight
        Arcadium/Rio Tinto
        • Deal Insight
        Fuji Soft/KKR
        • Deal Insight
        Walgreens Boots Alliance/Sycamore Partners
        • Deal Insight
        BP Sondrio/BPER
        • Deal Insight
        Altair/Siemens
        • Deal Insight
        Aspen Technology/Emerson Electric
        • Deal Insight
        Berry Global/Amcor
        • Deal Insight
        DS Smith/Mondi
        • Deal Insight
        Hargreaves Lansdown/CVC-led Consortium
        • Deal Insight
        Intra-Cellular Therapies/Johnson & Johnson
        • Deal Insight
        Neoen/Brookfield
        • Deal Insight
        Shinko Electric Industries/JIC-led Consortium
        • Deal Insight
        Summit Materials/Quikrete
        • Deal Insight
        Banca Generali/Mediobanca
        • Deal Insight
        Baloise/Helvetica
        • Deal Insight
        Topcon/KKR & JICC
        • Deal Insight
        Fortnox/EQT & First Kraft
        • Deal Insight
        AZEK/James Hardie
        • Deal Insight
        Beacon/QXO
        • Deal Insight
        Discover Financial Services/Capital One Financial
        • Deal Insight
        Parkland/Sunoco
        • Deal Insight
        Deliveroo/DoorDash
        • Deal Insight
        Skechers/3G Capital
        • Deal Insight
        TXNM Energy/Blackstone Infrastructure
        • Deal Insight
        Grupo Catalana/Inocsa
        • Deal Insight
        NTT Data/NTT
        • Deal Insight
        Chart/Flowserve
        • Deal Insight
  • Strategy
  • Contact
CONTACT

London

35 Berkeley Square
Mayfair
London
W1J 5BF
United Kingdom

+44 (0)20 3970 9998


FOLLOW

@ManaloArb
@ManaloAdvisors

REPORT ALERTS

Register your email address to receive an alert when we publish a new report.

Your personal details are safe with us. For more info, read our Privacy Policy.

  • Terms & Conditions
  • Privacy Policy
  • Site Map
  • © 2024 Manalo Advisors Limited – Manalo Advisors Limited is authorised and regulated by the Financial Conduct Authority.>>

Disclaimer

In order to view information on this website, you must accept the terms and conditions set out below (“the Terms”) and in our separate Terms & Conditions.

I confirm that:

  • I have read and accept the Terms & Conditions of using this Website.
  • I am a professional client or eligible counterparty for the purposes of the rules and guidance of the Financial Conduct Authority.
  • I recognise that the information provided on this website is for information purposes only and is not a solicitation of an investment.